GoCharlie.ai Developing Revolutionary Multimodal AI Model for Marketing with SRI International
SAN FRANCISCO–(BUSINESS WIRE)–#ai—GoCharlie.ai (“GoCharlie”), a Goodwater and XRC Ventures portfolio company, is receiving investment from…
SAN FRANCISCO–(BUSINESS WIRE)–#ai—GoCharlie.ai (“GoCharlie”), a Goodwater and XRC Ventures portfolio company, is receiving investment from…
PORTLAND, Ore.–(BUSINESS WIRE)–Standard Insurance Company (The Standard) announced today that Dave Friesen has been named…
ServiceNow to add G2K’s smart IoT technology to the Now Platform, enabling businesses to intelligently…
Industry recognition highlights Hitachi Vantara’s continued leadership and innovation in unstructured data, delivering cyber resiliency,…
PITTSBURGH–(BUSINESS WIRE)–PPG (NYSE PPG) today announced its Board of Directors was recognized by the National…
SALT LAKE CITY–(BUSINESS WIRE)–Atomic, a leading provider of payroll system integrations, has unveiled SmartAuth, a…
Wolters Kluwer Finance, Risk & Regulatory Reporting executives will offer banks perspective on achieving a…
Agreement Shows Confidence in Business Plan ALBANY, N.Y.–(BUSINESS WIRE)–Soluna Holdings, Inc. (“SHI” or the “Company”),…
Vancouver, British Columbia–(Newsfile Corp. – May 12, 2023) – Coloured Ties Capital Inc. (TSXV: TIE)…
HONG KONG, May 12, 2023 – (ACN Newswire) – VinFast Auto Pte. Ltd. (“VinFast” or…
NEW YORK–(BUSINESS WIRE)–The Buxton Helmsley Group, Inc. (together with certain of its affiliates, “BHG” or…
– Randomized clinical trial of IGM-8444 plus FOLFIRI and bevacizumab in second line metastatic colorectal…
IMCA medical center’s ethics committee approves clinical trial using proprietary CMND-100 treatment in Israel Tel…
NEXUS Phase 2 Clinical Trial of NX-13 for Ulcerative Colitis Initiated NEXUS Top-line Results Planned…
Table 1 FDA Required Primary Efficacy Endpoint Figure 2 Study BDX-22-006 Primary Endpoint Figure 3…
MIAMI, May 12, 2023 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the…
WALTHAM, Mass., May 12, 2023 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company…
Company has sufficient cash expected to fund operations through 2024 Carlsbad, CA, May 12, 2023 (GLOBE…
LONDON, May 12, 2023 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced…
OXFORD, United Kingdom, May 12, 2023 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC) (the Company,…